Algert Global LLC
- SEC CIK
- 0001275218
- Latest filing
- Aug 13, 2026
TBPH holding history
Theravance Biopharma, Inc. in every 13F filed by Algert Global LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TBPH overviewAll 13F holders of TBPHFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −199,705−100.0% | Sold out | Holders |
| Q3 2025 | 199,705 | $2.92M | <0.1% | +199,705 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −105,609−100.0% | Sold out | Holders |
| Q3 2024 | 105,609 | $851.2K | <0.1% | +105,609 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −30,700−100.0% | Sold out | Holders |
| Q3 2022 | 30,700 | $311.0K | <0.1% | −39,190−56.1% | Reduced | Holders |
| Q2 2022 | 69,890 | $633.0K | <0.1% | +49,160+237.1% | Added | Holders |
| Q1 2022 | 20,730 | $198.0K | <0.1% | −11,000−34.7% | Reduced | Holders |
| Q4 2021 | 31,730 | $351.0K | <0.1% | +13,350+72.6% | Added | Holders |
| Q3 2021 | 18,380 | $136.0K | <0.1% | +18,380 | New | Holders |